India to United States: Fluticasone Export Trade Route
India has recorded 58 verified shipments of Fluticasone exported to United States, representing a combined trade value of $1.0M USD. This corridor is served by 9 active Indian exporters, with an average shipment value of $18.1K USD. The leading Indian exporter is CIPLA LIMITED, which accounts for 95% of total export value with 8 shipments worth $999.5K USD. On the buying side, MYLAN SPECIALTY LP.FKA DEY PAHRAM,L is the largest importer in United States with $391.0K USD in purchases. The top 3 suppliers — CIPLA LIMITED, LUPIN LIMITED, GLOBAL HEALTHCARE — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Fluticasone corridor is one of India's established pharmaceutical export routes, with 58 shipments documented worth a combined $1.0M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 95% of all export value, reflecting the consolidated nature of India's fluticasone manufacturing sector.
Across 9 active suppliers, the average shipment value stands at $18.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during January–March, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 10.1%, placing it at rank #14 among India's top fluticasone export destinations globally.
On the import side, key buyers of Indian fluticasone in United States include MYLAN SPECIALTY LP.FKA DEY PAHRAM,L, MYLAN PHARMACEUTICALS INC GREENSBOR, MYLAN SPECIALTY LP,FKA DEY PAHRAM, and 19 others. MYLAN SPECIALTY LP.FKA DEY PAHRAM,L is the single largest importer with 2 shipments valued at $391.0K USD.
Route Characteristics
- Average transit30 days
- Peak seasonQ1
- Primary modeMulti-modal
- Top portSAHAR AIR
Market Position
- Global rank#14
- Annual growth+10.1%
- Demand growth+11.0%
- Regulatory ease70/100
Top 10 Indian Fluticasone Exporters to United States
Showing top 10 of 9 Indian suppliers exporting Fluticasone to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPLA LIMITED Avg $124.9K per shipment | 8 | $999.5K | 95.3% |
| 2 | LUPIN LIMITED Avg $4.5K per shipment | 10 | $44.6K | 4.3% |
| 3 | GLOBAL HEALTHCARE Avg $263 per shipment | 8 | $2.1K | 0.2% |
| 4 | ALLMPUS LABORATORIES PRIVATE LIMITED Avg $1.9K per shipment | 1 | $1.9K | 0.2% |
| 5 | TULSI MEDICAL & GENERAL STORES Avg $37 per shipment | 8 | $294 | 0.0% |
| 6 | VEA IMPEX (I) PRIVATE LIMITED Avg $26 per shipment | 10 | $263 | 0.0% |
| 7 | GLENMARK PHARMACEUTICALS LIMITED Avg $8 per shipment | 7 | $57 | 0.0% |
| 8 | DR.REDDY'S LABORATORIES LIMITED Avg $2 per shipment | 1 | $2 | 0.0% |
| 9 | VEEDA CLINICAL RESEARCH PRIVATE LIMITED Avg $0 per shipment | 5 | $0 | 0.0% |
This table shows the top 10 of 9 Indian companies exporting fluticasone to United States, ranked by total trade value. The listed exporters are: CIPLA LIMITED, LUPIN LIMITED, GLOBAL HEALTHCARE, ALLMPUS LABORATORIES PRIVATE LIMITED, TULSI MEDICAL & GENERAL STORES, VEA IMPEX (I) PRIVATE LIMITED, GLENMARK PHARMACEUTICALS LIMITED, DR.REDDY'S LABORATORIES LIMITED, VEEDA CLINICAL RESEARCH PRIVATE LIMITED. CIPLA LIMITED is the dominant supplier with 8 shipments worth $999.5K USD, giving it a 95% market share. The top 3 suppliers together account for 100% of the total trade value on this route.
Top 10 Fluticasone Importers in United States
Showing top 10 of 22 known buyers in United States receiving Fluticasone shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian fluticasone in United States include MYLAN SPECIALTY LP.FKA DEY PAHRAM,L, MYLAN PHARMACEUTICALS INC GREENSBOR, MYLAN SPECIALTY LP,FKA DEY PAHRAM,, MYLAN PHARMACEUTICALS INC, LUPIN RESEARCH INC, among 22 total buyers. The largest importer is MYLAN SPECIALTY LP.FKA DEY PAHRAM,L, accounting for $391.0K USD across 2 shipments — representing 37% of all fluticasone imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MYLAN SPECIALTY LP.FKA DEY PAHRAM,L | 2 | $391.0K | 37.3% |
| 2 | MYLAN PHARMACEUTICALS INC GREENSBOR | 1 | $211.0K | 20.1% |
| 3 | MYLAN SPECIALTY LP,FKA DEY PAHRAM, | 1 | $210.1K | 20.0% |
| 4 | MYLAN PHARMACEUTICALS INC | 1 | $186.6K | 17.8% |
| 5 | LUPIN RESEARCH INC | 10 | $44.6K | 4.3% |
| 6 | UNITED AMERICA GROUP LLC. | 1 | $1.9K | 0.2% |
| 7 | ABRAHAM PACHECO | 6 | $1.9K | 0.2% |
| 8 | INVAGEN PHARMACEUTICALS A CIPLA SUBSUDIARY | 3 | $688 | 0.1% |
| 9 | TO THE ORDER OF INVOICE RAISED TO | 10 | $263 | 0.0% |
| 10 | ELIZABETH ORNELAS | 2 | $240 | 0.0% |
Showing top 10 of 22 Fluticasone importers in United States on this route.
Top 10 Fluticasone Formulations Imported by United States
Showing top 10 of 30 product formulations shipped on the India to United States Fluticasone route, ranked by trade value
United States imports a wide range of fluticasone formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — AZELASTINE HYDROCHLORIDE 137MCG+FLUTICASONE PROPIONATE 50MCG (PER SPRAY)[P/S:1X120MD]QTY:30720 PAC — accounts for $211.0K USD across 1 shipments. There are 30 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | AZELASTINE HYDROCHLORIDE 137MCG+FLUTICASONE PROPIONATE 50MCG (PER SPRAY)[P/S:1X120MD]QTY:30720 PAC | 1 | $211.0K | 20.1% |
| 2 | DYMISTA NASAL SPRAY (AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE NASALSPRAY 137/50MCG) | 1 | $210.1K | 20.0% |
| 3 | Dymista Nasal Spray(Azelastine Hydrochloride and Fluticasone propionate Nasal Spray 137/50mcg)[P/S:1X120MD]QTY:29840 PAC | 1 | $205.0K | 19.5% |
| 4 | AZELASTINE HYDROCHLORIDE 137MCG+FLUTICASONE PROPIONATE 50MCG (PER SPRAY)NASAL SUSPENSION (PS:1X120MD) | 1 | $186.6K | 17.8% |
| 5 | Dymista Nasal Spray (Azelastine Hydrochloride and Fluticasone propionate Nasal Spray 137/50mcg)(PS:1X120MD) | 1 | $186.0K | 17.7% |
| 6 | FLUTICASONE FUROATE 100 MCG. UMECLIDINIU | 3 | $22.9K | 2.2% |
| 7 | BREO ELLIPTA (FLUTICASONE FUROATE 100 MC | 2 | $20.8K | 2.0% |
| 8 | FURAMIST NASAL SPRAY (FLUTICASONE FUROATE NASAL SPRAY) | 8 | $2.1K | 0.2% |
| 9 | FLUTICASONE EP IMPURITY J (50MG, 1 * VIAL) B/N. ALL-F06863 | 1 | $1.9K | 0.2% |
| 10 | FLUTICASONE PROPIONATE 111MCG INHALATIONAEROSOL 120 MD | 3 | $688 | 0.1% |
Showing top 10 of 30 Fluticasone formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 69% sea for bulk, 18% air for urgent orders.
Top Ports of Origin
SAHAR AIR handles the highest volume with 28 shipments. Transit time averages 30 days by sea.
Market Dynamics
India's fluticasone exports to United States are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 8 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 9 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — CIPLA LIMITED, LUPIN LIMITED, GLOBAL HEALTHCARE — together account for 100% of total trade value on this route. The average shipment value of $18.1K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as dymista nasal spray (azelastine hydrochloride and fluticasone propionate nasalspray 137/50mcg) and dymista nasal spray(azelastine hydrochloride and fluticasone propionate nasal spray 137/50mcg)[p/s:1x120md]qty:29840 pac, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, MYLAN SPECIALTY LP.FKA DEY PAHRAM,L is the largest importer with 2 shipments worth $391.0K USD — representing 37% of all fluticasone imports from India on this route. A total of 22 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $1.0M
- Avg. Shipment
- $18.1K
- Suppliers
- 9
- Buyers
- 22
- Transit (Sea)
- ~30 days
- Annual Growth
- +10.1%
Related Analysis
Reverse Direction
United States → India — Fluticasone (Import)Other Fluticasone Routes
Unlock the Full India to United States Fluticasone Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 58 shipments on this route.
Frequently Asked Questions — India to United States Fluticasone Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Fluticasone to United States?
The leading Indian exporters of Fluticasone to United States are CIPLA LIMITED, LUPIN LIMITED, GLOBAL HEALTHCARE. CIPLA LIMITED holds the largest market share at approximately 95% of total trade value on this route.
Q What is the total value of Fluticasone exports from India to United States?
India exports Fluticasone to United States worth approximately $1.0M USD across 58 recorded shipments. The average value per shipment is $18.1K USD.
Q Which ports does India use to ship Fluticasone to United States?
The most active port of origin is SAHAR AIR with 28 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 69% of shipments going by sea and 18% by air.
Q How long does shipping take from India to United States for Fluticasone?
The average transit time for Fluticasone shipments from India to United States is approximately 30 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to United States Fluticasone trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 10.1% with demand growth tracking at 11.0%. The route is ranked #14 among India's top Fluticasone export destinations globally.
Q How many suppliers are active on the India to United States Fluticasone route?
There are currently 9 active Indian suppliers exporting Fluticasone to United States. The market is moderately concentrated with CIPLA LIMITED accounting for 95% of total shipment value.
Q Who are the main importers of Fluticasone from India in United States?
The leading importers of Indian Fluticasone in United States include MYLAN SPECIALTY LP.FKA DEY PAHRAM,L, MYLAN PHARMACEUTICALS INC GREENSBOR, MYLAN SPECIALTY LP,FKA DEY PAHRAM,, MYLAN PHARMACEUTICALS INC, LUPIN RESEARCH INC. MYLAN SPECIALTY LP.FKA DEY PAHRAM,L is the largest buyer with 2 shipments worth $391.0K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Fluticasone.
- 2.Supplier/Buyer Matching: 9 Indian exporters and 22 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 58 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
58 Verified Shipments
9 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists